SAN DIEGO, October 08, 2017—Findings from a retrospective chart review revealed that 3 months of rifapentine + isoniazid using directly observed therapy (3HP) resulted in a higher completion rate and no loss of follow-up vs. treatment with the traditional 9 months of isoniazid (9H) for latent tuberculosis infection (LTBI).
